Are clinical laboratories in California accurately reporting vancomycin- resistant enterococci?

Journal of Clinical Microbiology

Volumn 35, Issue 10, 1997, Pages 2526-2530

  Rosenberg, Jon ^a   Tenover, Fred C ^b   Wong, Jane ^a   Jarvis, William ^b   Vugia, Duc J ^a  

^a Division of Communicable Disease Control   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; GOOD LABORATORY PRACTICE; LABORATORY; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; UNITED STATES;

ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; STREPTOCOCCUS;

EID: 0030808486     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.10.2526-2530.1997     Document Type: Article

References (39)

1. ASM Task Force on Antibiotic Resistance. 1995. Report of the ASM Task Force on Antibiotic Resistance. American Society for Microbiology, Washington, D.C.
2. Boyce, J. M., S. M. Opal, J. W. Chow, M. J. Zervos, G. Potter-Byone, C. B. Sherman, R. L. C. Romulo, S. Fortna, and A. A. Medeiros. 1994. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J. Clin. Microbiol. 32:1148-1153.
3. Boyle, J. F., S. A. Soumakis, A. Rendo, J. A. Herrington, D. G. Gianarkis, B. E. Thurberg, and B. G. Painter. 1993. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J. Clin. Microbiol. 31:1280-1285.
4. Centers for Disease Control and Prevention. 1994. Addressing emerging infectious disease threats. A prevention strategy for the United States. Centers for Disease Control and Prevention, Atlanta, Ga.
5. Centers for Disease Control and Prevention. 1995. Statewide surveillance for antibiotic-resistant bacteria - New Jersey, 1992-1994. Morbid. Mortal. Weekly Rep. 44:504-506.
6. Centers for Disease Control and Prevention. 1996. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci - 1994. Morbid. Mortal. Weekly Rep. 45:289-291.
7. Frieden, T. R., S. S. Munsiff, D. E. Low, B. M. Wiley, G. Williams, Y. Faur, W. Eisner, S. Warren, and B. Kreisworth. 1993. Emergence of vancomycin-resistant enterococci in New York City. Lancet 342:76-79.
8. Gaynes, R. 1995. Surveillance of antibiotic resistance: learning to live with bias. Infect. Control Hosp. Epidemiol. 16:623-626.
9. Handwerger, S., B. Raucher, D. Altarac, J. Monka, S. Marchione, K. V. Singh, B. E. Murray, J. Wolff, and B. Walters. 1993. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin. Infect. Dis. 16:750-755.
10. Hospital Infection Control Practices Advisory Committee. 1995. Recommendations for preventing the spread of vancomycin-resistant enterococci. Infect. Control Hosp. Epidemiol. 16:105-113.
11. Institute of Medicine. 1992. Emerging infections: microbial threats to health in the United States. National Academy Press, Washington, D.C.
12. Iwen, P. C., D. M. Kelly, J. Lindner, and S. H. Hinrichs. 1996. Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels. J. Clin. Microbiol. 34:1779-1783.
13. Kaplan, A. H., P. H. Gilligan, and R. R. Facklam. 1988. Recovery of resistant enterococci during vancomycin prophylaxis. J. Clin. Microbiol. 26:1216-1218.
14. Karanfil, L. V., M. Murphy, A. Josephson, R. Gaynes, L. Mandel, B. C. Hill, and J. M. Swenson. 1992. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect. Control Hosp. Epidemiol. 13:195-200.
15. Krogstad, D. J., T. R. Korfhagen, R. C. Moellering, Jr., C. Wennersten, and M. N. Swartz. 1978. Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis: an explanation for antibiotic synergism. J. Clin. Invest. 62:480-486.
16. Leclerq, R., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161.
17. Lorian, V. 1995. The need for surveillance for antimicrobial resistance. Infect. Control Hosp. Epidemiol. 16:638-641.
18. Morris, J. G., Jr., D. K. Shay, J. N. Hebden, R. J. McCarter, B. E. Perdue, W. Jarvis, J. A. Johnson, T. C. Dowling, L. B. Polish, and R. S. Schwalbe. 1995. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann. Intern. Med. 123:250-259.
19. Murray, B. E. 1990. The life and times of the enterococcus. Clin. Microbiol. Rev. 3:46-65.
20. Murray, B. E. 1994. Can antibiotic resistance be controlled? N. Engl. J. Med. 330:1229-1230.
21. Murray, B. E., and B. Mederski-Samoraj. 1983. Transferable β-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J. Clin. Invest. 72:1168-1171.
22. National Committee for Clinical Laboratory Standards. 1991. Third information supplement M100-S3. Performance standards for antimicrobial susceptibility testing. National Committee for Clinical Laboratory Standards, Villanova, Pa.
23. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
24. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
25. Osterholm, M. T., and K. L. MacDonald. 1995. Antibiotic-resistant bugs: when, where, and why? Infect. Control Hosp. Epidemiol. 16:382-384.
26. Paul, S. M., L. Finelli, G. L. Crane, and K. C. Spitalny. 1995. A statewide surveillance system for antimicrobial-resistant bacteria: New Jersey. Infect. Control Hosp. Epidemiol. 16:385-390.
27. Rubin, L. G., V. Tucci, E. Cercenado, G. Eliopoulos, and H. D. Isenberg. 1992. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect. Control. Hosp Epidemiol. 13:700-705.
28. Sahm, D. F., and L. Olsen. 1990. In vitro detection of enterococcal vancomycin resistance. Antimicrob. Agents Chemother. 34:1846-1848.
29. Swenson, J. M., N. C. Clark, M. J. Ferraro, D. F. Sahm, G. Doern, M. A. Pfaller, L. B. Reller, M. P. Weinstein, R. J. Zabransky, G. L. Woods, and F. C. Tenover. 1994. Development of a standardized screening method for detection of vancomycin-resistant enterococci. J. Clin. Microbiol. 32:1700-1704.
30. Tenover, F. C., J. Tokars, J. Swenson, S. Paul, K. Spitalny, and W. Jarvis. 1993. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J. Clin. Microbiol. 31:1695-1699.
31. Tenover, F. C., J. Swenson, C. M. O'Hara, and S. A. Stocker. 1995. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J. Clin. Microbiol. 33:1524-1527.
32. Tomasz, A. 1994. Multiple-antibiotic resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N. Engl. J. Med. 330:1247-1251.
33. Walsh, C. T. 1993. Vancomycin resistance: decoding the molecular logic. Science 261:308-309.
34. Wells, C. L., B. A. Juni, S. B. Cameron, K. R. Mason, D. L. Dunn, P. Ferrieri, and F. S. Rhame. 1995. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin. Infect. Dis. 21:45-50.
35. Wiley, B. M., B. N. Kreiswirth, A. E. Simor, G. Williams, S. R. Scriver, A. Phillips, and D. E. Low. 1992. Detection of vancomycin resistance in Enterococcus species. J. Clin. Microbiol. 30:1621-1624.
36. Williamson, R., C. LeBouguenec, L. Gutmann, and T. Horaud. 1985. One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. J. Gen. Microbiol. 131:1933-1940.
37. Woodford, N., A. P. Johnson, D. Morrison, and D. C. E. Speller. 1995. Current perspectives on glycopeptide resistance. Clin. Microbiol. Rev. 8: 585-615.
38. Woods, G. L., and J. A. Washington. 1995. Antibacterial susceptibility tests: dilution and disk diffusion methods, p. 1327-1341. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
39. Zabransky, R. J., A. R. DiNuzzo, M. B. Huber, and G. L. Woods. 1994. Detection of vancomycin resistance in enterococci by the Vitek AMS system. Diagn. Microbiol. Infect. Dis. 20:113-116.